(NEW YORK) -- A new weight-loss treatment is being heralded by some health experts as "groundbreaking," and a potential "game changer" in the growing epidemic of obesity. Semaglutide, an injectable drug made by the pharmaceutical company Novo Nordisk, was approved Friday by the Food and... Read More.
Latest Local News
HALIBUT AND CHIPS OR CRAB LOUIE – YOU DECIDE
Calling all fishers and crabbers. Summer is here and ...